QFQiang Fu

Qiang Fu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Qiang Fu has a total of 47 co-authors. Here are the top co-authors by number of shared publications:

  • Guizhi Zhang

    Department of Nuclear Medicine, Tianjin Medical University General Hospital, Tianjin, PR China

    2 shared publications
  • Jian Tan

    Department of Nuclear Medicine, Tianjin Medical University General Hospital, Tianjin, PR China

    2 shared publications
  • Jianping Zhang

    Department of Nuclear Medicine, Tianjin Medical University General Hospital, Tianjin, PR China

    2 shared publications
  • Ke Xu

    Tianjin Key Laboratory of Lung Cancer Metastasis and Tumor Microenvironment, Tianjin Lung Cancer Institute, Tianjin Medical University General Hospital, China

    2 shared publications
  • Li Xue

    Affiliation Department of Urology, The Second Affiliated Hospital of Xi’an Jiaotong University, Xi’an, China

    2 shared publications
  • Qiang Jia

    Shandong Academy of Occupational Health and Occupational Medicine, Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan, Shandong, 250062, China

    2 shared publications

Latest Publications

  • Open Access

    MicroRNA 27b promotes cardiac fibrosis by targeting the FBW7/Snail pathway

    by Qiang Fu, Zhihong Lu, Xiao Fu, Shitang Ma, Xiaochun Lu

    Our study aspires to understand the impact of miR-27b on myocardial fibrosis as well as its functional mechanism. 12 days post the ligation of coronary artery in rats, the expression of miR-27b in the peri-infarction region was elevated. Treating cultivated rat neonatal cardiac fibroblasts (CFs) with angiotensin II (AngII) also enhanced the miR-27b expression. Forced expression of miR-27b promoted the proliferation and collagen production in rat neonatal CFs, as revealed by cell counting, MTT assay, and quantitative reverse transcription-polymerase chain reaction. FBW7 was found to be the miR-27b's target since the overexpression of miR-27b reduced the transcriptional level of FBW7. The enhanced expression of FBW7 protein abrogated the effects of miR-27b in cultured CFs, while the siRNA silence of FBW7 promoted the pro-fibrosis activity of AngII. As to the mechanism, we found that the expression of FBW7 led to the degradation of Snail, which is an important regulator of cardiac epithelial-mesenchymal transitions. Importantly, inhibition of miR-27b abrogated the coronary artery ligation (CAL) induced cardiac fibrosis in vivo, suggesting that it might be a potential target for the treatment of fibrosis associated cardiac diseases.


  • Open Access

    Lapatinib, trastuzumab or the combination added to neoadjuvant chemotherapy for breast cancer

    by Quan Liang, Qiang Fu, Wei Li, Jiacong You, Zhanchao Zhao

    The aim of this study was to compare the efficacy and safety of trastuzumab versus the combination of trastuzumab and lapatinib added to neoadjuvant chemotherapy for HER2 positive breast cancer. PubMed, MEDLINE, The Cochrane Library, Web of Science and nearly 5 years of the important international conference on oncology records were searched for randomized clinical trials that compared lapatinib plus trastuzumab and neoadjuvant chemotherapy (NAC) with trastuzumab in combination with NAC and that included pathologic complete response rate as the primary outcome. Finally, 6 clinical randomized controlled trials were included. Meta-analysis shows that pathological complete response rate was significantly increased in trastu-zumab plus lapatinib group than single use trastuzumab group (53.4%, 40.4%, RR = 1.75, 95% CI 1.38 ~ 2.23, p<0.001). In conclusion, the combination of trastuzumab and lapatinib added to neoadjuvant chemotherapy in HER2 positive breast cancer is more effective.

  • Open Access

    Advancement of Wnt signal pathway and the target of breast cancer

    by Quan Liang, Wei Li, Zhanchao Zhao, Qiang Fu

    Wnt/β-catenin signaling has been proved to play an important role in the development and promotion of cancer metastasis. The activation of Wnt signals can lead to duplicating, updating, metastasizing and relapsing. The Wnt signaling pathway is mainly divided into the Wnt/β-catenin pathway and the Wnt/calcium pathway. A better understanding of all the diverse functions of Wnt and their molecular mechanisms has evoked prevailing interest in identifying additional targets related to the Wnt /β-catenin pathways in breast cancer. A number of new target, related to Wnt /β-catenin pathways have been identified in recent years, including NOP14, BKCa channels, Emilin2, WISP, MicroRNAs, NRBP1, TRAF4, and Wntless. In this review, we will introduce the new targets related to the Wnt /β-catenin pathways in breast cancer


  • Evaluation of serum midkine as a biomarker in differentiated thyroid cancer

    by Zhaowei Meng, Jian Tan, Guizhi Zhang, Weijun Tian, Qiang Fu, Weidong Li, Xianghui He, Shuanghu Wu, Zhiqiang Yang, Xiaoyu Liang, et al.


  • Immunohistochemical evaluation of midkine and nuclear factor-kappa B as diagnostic biomarkers for papillary thyroid cancer and synchronous metastasis

    by Yujie Zhang, Zhaowei Meng, Mingfang Zhang, Jian Tan, Weijun Tian, Xianghui He, Qiang Fu, Ke Xu, Qing He, Mei Zhu, et al.


    • 1 January 2014
      • Vol. 127  (8) , 1497-503

    Clinical outcome of ileal pouch-anal anastomosis for chronic ulcerative colitis in China.

    by Gang Liu, Hongqiu Han, Tong Liu, Qiang Fu, Yongcheng Lyu

    The incidence of chronic ulcerative colitis (CUC) in China is remarkably increasing, while little information on surgical treatment has been reported. This study aimed to completely describe and analyze the clinical outcome of restorative proctocolectomy with ileal pouch-anal anastomosis (IPAA) for CUC in China. Ninety-five consecutive patients, who suffered CUC and had surgical indications, were carefully selected. All patients underwent IPAA. Data on patient characteristics, surgical indications, surgical details, postoperative complications, functional outcome, and quality of life were collected. The mean patient age at the time of the operation was 32 years. Twenty-nine (31%) patients underwent an emergency operation, and 66 (69%) underwent elective procedures. Four patients with severe dysplasia underwent operations, but no carcinoma was histologically confirmed. A two-stage operation was performed in 87 (92%) patients, and a hand-sewn technique was applied in 88 (93%) patients. Sixteen patients (17.0%) experienced early complications, and there was a significant difference between the emergency surgery group and the elective group (31.0% vs. 10.6%, respectively; P < 0.01). Five (5.3%) patients developed pouchitis as a late complication. The mean stool frequency after the operation was 4.6 (2-11) during the first 24 hours and 1.5 (0-4) overnight. According to the Kirwan grading scale, 87 (91.8%) patients showed satisfactory anal continence function. The quality of life improved significantly from a preoperative mean value of 0.28-0.61 before ileostomy closure to 0.78 after ileostomy closure (P < 0.01) according to the Cleveland Global Quality of Life index. IPAA is an effective and safe surgical procedure for patients with CUC in China. However, some characteristics, such as the low incidence of pouchitis, require further study.


  • Open Access

    Optical absorption, Raman spectra and TEM study of Ag nanoparticles formed by ion implantation into a-SiO2

    by Liu Xiang-Fei, Changzhong Jiang, Feng Ren, Qiang Fu

    能量为200keV的Ag离子,以1×1016,5×1016,1×1017 cm-2的剂量分别注入到非晶SiO2玻璃,光学吸收谱显示:注入剂量为1×1016 cm-2的样品的光吸收谱为洛伦兹曲线,与Mie理论模拟的曲线形状一致;注入剂量较大的5×1016,1×1017 cm-2的谱线共振吸收增强,峰位红移并出现伴峰. 透射电镜观察分析表明,注入剂量不同的样品中形成的纳米颗粒的大小、形状、分布都不同,注入剂量较大的还会产生明显的表面溅射效应,这些因素都会影响共振吸收的峰形、峰位和峰强. 当注入剂量达到1×1017 cm-2时,Ag纳米颗粒内部可能还形成了杂质团簇.